Search for the latest oncology news by tumour type
Breast cancer survivors who participated in Active Living After Cancer, an evidence-based 12-week group program,…
Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head…
Children with Down’s syndrome have a lower chance of survival from ALL than children without…
The RACE AI study conducted by Gustave Roussy and the startup Owkin, as part of…
An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three…
Highlights on pembrolizumab in fully resected high-risk stage II melanoma: KEYNOTE-716 study
Highlights on patterns of relapse in non-small cell lung cancer to atezolizumab vs best supportive…
Highlights on combination of pembrolizumab plus chemotherapy in metastatic triple-negative breast cancer: The KEYNOTE-355 study
Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
Highlights on atezolizumab combined with FOLFOXIRI + bevacizumab in 1st-line metastatic colorectal cancer: AtezoTRIBE study